
CNXC Stock Forecast & Price Target
CNXC Analyst Ratings
Bulls say
Concentrix is expected to continue gaining market share and wallet share in their high growth verticals, which will lead to increased revenue growth in fiscal 2026. Despite recent acquisition-related expenses and loss on held for sale, investors are pricing in a worst-case scenario, making the risk/reward balance favorable for investing. Additionally, macro and reputation risks should be considered but are unlikely to significantly impact the company's strong earnings outlook.
Bears say
Concentrix is heavily dependent on a limited number of clients, with the top five customers accounting for about 25% of its revenue. Additionally, the company's future growth is heavily reliant on its ability to execute its strategy of transitioning towards a more technology-focused business model, which may be challenging. The company has also experienced some customer concentration in the healthcare industry due to reduced Affordable Care Act participation among key clients. These factors, combined with the company's current valuation, lead to a negative outlook on the stock.
This aggregate rating is based on analysts' research of Concentrix Corporation and is not a guaranteed prediction by Public.com or investment advice.
CNXC Analyst Forecast & Price Prediction
Start investing in CNXC
Order type
Buy in
Order amount
Est. shares
0 shares